-
J. Thromb. Haemost. · Sep 2020
Practice GuidelineISTH DIC subcommittee communication on anticoagulation in COVID-19.
- Jecko Thachil, Nicole P Juffermans, Marco Ranucci, Jean M Connors, Theodore E Warkentin, Thomas L Ortel, Marcel Levi, Toshiaki Iba, and Jerrold H Levy.
- Department of Haematology, Manchester University Hospitals, Manchester, UK.
- J. Thromb. Haemost. 2020 Sep 1; 18 (9): 2138-2144.
AbstractHypercoagulability is an increasingly recognized complication of SARS-CoV-2 infection. As such, anticoagulation has become part and parcel of comprehensive COVID-19 management. However, several uncertainties exist in this area, including the appropriate type and dose of heparin. In addition, special patient populations, including those with high body mass index and renal impairment, require special consideration. Although the current evidence is still insufficient, we provide a pragmatic approach to anticoagulation in COVID-19, but stress the need for further trials in this area.© 2020 International Society on Thrombosis and Haemostasis.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..